Pfizer Balance Sheet Health
Financial Health criteria checks 1/6
Pfizer has a total shareholder equity of $89.3B and total debt of $72.2B, which brings its debt-to-equity ratio to 80.8%. Its total assets and total liabilities are $226.5B and $137.2B respectively. Pfizer's EBIT is $5.3B making its interest coverage ratio 48.2. It has cash and short-term investments of $12.7B.
Key information
80.8%
Debt to equity ratio
US$72.18b
Debt
Interest coverage ratio | 48.2x |
Cash | US$12.69b |
Equity | US$89.29b |
Total liabilities | US$137.21b |
Total assets | US$226.50b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: PFEB's short term assets ($43.3B) do not cover its short term liabilities ($47.8B).
Long Term Liabilities: PFEB's short term assets ($43.3B) do not cover its long term liabilities ($89.4B).
Debt to Equity History and Analysis
Debt Level: PFEB's net debt to equity ratio (66.6%) is considered high.
Reducing Debt: PFEB's debt to equity ratio has increased from 66.1% to 80.8% over the past 5 years.
Debt Coverage: PFEB's debt is not well covered by operating cash flow (12.1%).
Interest Coverage: PFEB's interest payments on its debt are well covered by EBIT (48.2x coverage).